Bristol-Myers Squibb Co. (BMY) PT Raised to $66 at Truist Securities
- Wall Street slips off record highs, Tesla drops after fatal crash
- IBM (IBM) Tops Q1 EPS by 14c, Revenue Beats
- Tesla's (TSLA) Musk says data logs recovered from crash show Autopilot was not enabled & this car did not purchase FSD
- Bitcoin (BTC) Price Fell 20% Off the Highs Over the Weekend as Markets Got 'Too Excited' About Coinbase (COIN), Says Mike Novogratz
- GameStop (GME) CEO Gets the Axe as Ryan Cohen Continues to Make His Mark, Analyst Says Co. Will Likely Look to Tech Sector for New Hires
Truist Securities raised its price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $66.00 (from $65.00) while maintaining a Hold rating.
You May Also Be Interested In
- WEX Inc. (WEX) PT Raised to $237 at BofA Securities
- Shree Cement Ltd (SRCM:IN) PT Raised to INR32,500 at Citi
- Grasim Industries Ltd (GRASIM:IN) PT Raised to INR1,750 at Citi
Create E-mail Alert Related CategoriesAnalyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!